MedPath
FDA Product

Daypro

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Daypro

0025-1381

Regulatory Information

0025-1381

NDA018841

C73594

November 17, 2022

USA

These highlights do not include all the information needed to use DAYPRO safely and effectively. See full prescribing information for DAYPRO. DAYPRO (oxaprozin) caplets, for oral useInitial U.S. Approval: 1992

HUMAN PRESCRIPTION DRUG LABEL

20

Company Information

Pfizer Laboratories Div Pfizer Inc

134489525

Active Ingredients

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

OXAPROZIN

Quantity: 600 mg in 1 1

Code: MHJ80W9LRB

Class Code: ACTIB

METHYLCELLULOSE (100 MPA.S)

Code: 4GFU244C4J

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

POLACRILIN POTASSIUM

Code: 0BZ5A00FQU

Class Code: IACT

POLYETHYLENE GLYCOL, UNSPECIFIED

Code: 3WJQ0SDW1A

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

Active Moieties

OXAPROZIN

Code: MHJ80W9LRB

© Copyright 2025. All Rights Reserved by MedPath